drugset / Trial / NCT05209867
Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV
Phase 4
Completed
4 enrolled
University of Florida
Consortium for Medical Marijuana Clinical Outcomes Research · collab
NaSingle-groupOpen-labelTreatment
Summary
People living with HIV (PLWH) are affected by comorbidities appearing to be strongly related to chronic inflammation, a condition characterizing PLWH. The investigators propose to study the effects of CBD on inflammation in PLWH, and establish the molecular role of different immune cells in this process. The investigators plan to use single cell RNA-sequencing (scRNAseq) to isolate CBD-specific cellular phenotypes from five persons with HIV who will provide blood samples before and after taking CBD.
Timeline
- Start
- 2022-05-01
- Primary completion
- 2022-12-12
- Completion
- 2022-12-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 63 mg | Other |